Free. Unsubscribe any time.
AGIOS PHARMACEUTICALS, INC. (AGIO)
AGIOS PHARMACEUTICALS, INC. filed 47 Form 4 statements naming a Rule 10b5-1 trading plan in the 2025 filing year, by 9 reporting owners, covering 72 transactions and 249,369 shares. None carries the SEC's AFF10B5ONE flag; all 47 name a plan in a footnote. 7 results prints are on file in the same window.
What stands out
- The most recent filing on file, dated 2026-08-06, came 35 days after the one before it (2026-07-02) and reports 1 transaction against 3 in the filing before it.
- The sales it reports total 30,000 shares, 25,993 more than the 4,007 in the filing before it.
- Its 47 plan statements rank 114th of the 483 companies the register carries in Delaware, its state of incorporation.
- Of the 10 companies the register lists beside it in its industry, 2 have more plan statements on file than it and 8 have fewer.
- Its 47 filings on file run from 2025-01-07 to 2026-08-06, and state no plan adoption date.
Trades in AGIOS PHARMACEUTICALS, INC. 72
- Milanova Tsveta — 2025-01-06 · S · 2,804 shares
- Washburn Theodore James Jr. — 2025-02-05 · S · 2,272 shares
- Burns James William — 2025-03-03 · S · 1,137 shares
- Burns James William — 2025-03-03 · S · 1,187 shares
- Burns James William — 2025-03-03 · S · 1,681 shares
- Gheuens Sarah — 2025-03-03 · S · 1,137 shares
- Gheuens Sarah — 2025-03-03 · S · 1,187 shares
- Gheuens Sarah — 2025-03-03 · S · 1,681 shares
- Goff Brian — 2025-03-03 · S · 4,153 shares
- Goff Brian — 2025-03-03 · S · 8,794 shares
- Jones Cecilia — 2025-03-03 · S · 594 shares
- Jones Cecilia — 2025-03-03 · S · 1,681 shares
Adoption dates in AGIOS PHARMACEUTICALS, INC. 0
Results prints in AGIOS PHARMACEUTICALS, INC. 7
- 2025-02-13
- 2025-05-01
- 2025-07-31
- 2025-10-30
- 2026-02-12
- 2026-04-29
- 2026-07-30
Trades before a print in AGIOS PHARMACEUTICALS, INC. 2
- 0 days before the 2025-10-30 print — 2025-10-30 · S · Gheuens Sarah · 200 shares
- 3 days before the 2025-10-30 print — 2025-10-27 · S · Gheuens Sarah · 3,302 shares
- 8 days before the 2025-02-13 print — 2025-02-05 · S · Washburn Theodore James Jr. · 2,272 shares
- 21 days before the 2025-05-01 print — 2025-04-10 · S · FOUSE JACQUALYN A · 7,497 shares
- 21 days before the 2025-07-31 print — 2025-07-10 · S · Scadden David · 1,400 shares
- 22 days before the 2025-07-31 print — 2025-07-09 · S · Gheuens Sarah · 11,067 shares
- 22 days before the 2025-07-31 print — 2025-07-09 · S · Gheuens Sarah · 847 shares
- 22 days before the 2025-10-30 print — 2025-10-08 · S · Scadden David · 200 shares
- 27 days before the 2026-04-29 print — 2026-04-02 · S · Burns James William · 3,280 shares
- 27 days before the 2026-04-29 print — 2026-04-02 · S · Gheuens Sarah · 2,940 shares
- 27 days before the 2026-04-29 print — 2026-04-02 · S · Goff Brian · 12,472 shares
- 27 days before the 2026-04-29 print — 2026-04-02 · S · Goff Brian · 6,596 shares
Interval to AGIOS PHARMACEUTICALS, INC.’s next reported results date
How the interval and sources are counted →
- 2within 5 days
- 3within 10 days
- 0shortest, days
- 1no later print
- Washburn Theodore James Jr. 2025-02-05 · S · 8 days before the 2025-02-13 print · Principal Accounting Officer
- Gheuens Sarah 2025-10-27 · S · 3 days before the 2025-10-30 print · Chief Medical Officer
- Gheuens Sarah 2025-10-30 · S · 0 days before the 2025-10-30 print · Chief Medical Officer
Reported results dates on file
- 2025-02-13
- 2025-05-01
- 2025-07-31
- 2025-10-30
- 2026-02-12
- 2026-04-29
- 2026-07-30
A proxy statement is on file for this company in the same window, which is where a company states its own trading policy.
Other companies with plan records
- BRISTOL MYERS SQUIBB CO 2
- FMC CORP 2
- ELI LILLY & Co 11
- ABEONA THERAPEUTICS INC. 7
- HEXCEL CORP /DE/ 2
- TEVA PHARMACEUTICAL INDUSTRIES LTD 37
- Lifevantage Corp 3
- IONIS PHARMACEUTICALS INC 86
- VERTEX PHARMACEUTICALS INC / MA 74
- ARROWHEAD PHARMACEUTICALS, INC. 23
Sources: SEC EDGAR full-text search and the SEC submissions API.